Abstract
Therapeutic Efficacy of Acupuncture and Electroacupuncture in Treating Somatic Symptoms from the Psychosomatic Medicine Perspective
Department of Traditional Chinese Medicine, Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, 1Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine, Tianjin 300120, China
Correspondence Address:
Yan Mei, Department of Traditional Chinese Medicine, Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine, Tianjin 300120, China, E-mail: nuodun@163.com
To observe and explore the clinical effect of Chinese acupuncture and electro acupuncture in the treatment of somatic symptoms and to analyze the mechanism of action. 77 patients with psychosomatic symptoms who were treated from July 2022 to July 2023 in Affiliated Hospital of Tianjin University of Chinese Medicine from July 2023 were divided into 38 patients in acupuncture treatment group (acupuncture combined with electroacupuncture therapy and with or without drugs) and 39 patients in non-acupuncture treatment group (other conventional treatment group that had not received acupuncture). Compare the symptom check list 90, cornell medical index and WCPA somatic symptoms rating scale, clinical global impression scales before and after 4 w of treatment. None of the four scales was statistically significant before treatment (p>0.05), and comparison of symptom self-rating scale (symptom check list 90) (p<0.05). Comparison of cornell medical index table; within and between groups (p<0.05). Comparison of clinical somatic symptoms classification scale (WCPA) of Western psychiatric association; there was no significant difference between groups before and after (p>0.05), and the scores of WCPA scale A, C and D dimensions were significantly lower than that of non-acupuncture group, p<0.05, and the differences of B and E dimensions were not significant p>0.05. The overall clinical efficacy scale acupuncture treatment group was mostly mild and moderate (55 % and 36 %), acupuncture had no significant side effects (82 %), efficacy index was significant (p>1.0 points), response rate reached 81.82 %, and global improvement was significant improvement (46 %). After systematically evaluating the somatic symptoms and clinical efficacy of patients, it is sufficient evidence to provide more scientific and effective treatment plans for patients with psychosomatic symptom disorders, and to provide more accurate diagnosis and treatment methods for clinicians.
Full-Text | PDF